Overview Financials News + Filings Key Docs Charts Ownership Insiders |
Civeo Corp (CVEO)
|
Add to portfolio |
|
|
Price: |
$19.29
| | Metrics |
OS: |
14.2
|
M
| |
|
|
Market cap: |
$274
|
M
| |
|
|
Net debt:
|
$124
|
M
| |
|
|
EV:
|
$398
|
M
| | | |
| | | | | |
TTM Valuation | | | |
EBITDA
|
|
| |
|
|
EBIT
|
|
| |
|
|
EPS |
| |
|
|
|
| |
|
|
|
Recent News + Filings (All items)
|
Revenue Mix by Segment
|
Financial Summary (All financials)
In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 |
Revenues | 697.1 | 594.5 | 529.7 | 527.6 | 466.7 | 382.3 | 397.2 | 518.0 |
Revenue growth | 17.3% | 12.2% | 0.4% | 13.0% | 22.1% | -3.8% | -23.3% | -45.1% |
Cost of goods sold | 517.1 | 436.5 | 382.1 | 366.8 | 332.4 | 257.3 | 259.7 | 327.6 |
Gross profit | 180.0 | 158.0 | 147.6 | 160.7 | 134.3 | 125.0 | 137.6 | 190.4 |
Gross margin | 25.8% | 26.6% | 27.9% | 30.5% | 28.8% | 32.7% | 34.6% | 36.7% |
Selling, general and administrative | 70.0 | 60.6 | 53.7 | 59.6 | 67.0 | 63.4 | 55.3 | 68.4 |
EBITA | 17.0 | 20.0 | 11.0 | -8.1 | -41.8 | -59.1 | -42.4 | -14.5 |
EBITA margin | 2.4% | 3.4% | 2.1% | -1.5% | -9.0% | -15.5% | -10.7% | -2.8% |
Amortization of intangibles | | 6.0 | 14.1 | 14.8 | 17.6 | 7.3 | 7.2 | 7.6 |
EBIT | 17.0 | 14.0 | -3.1 | -22.9 | -59.4 | -66.4 | -49.6 | -22.1 |
EBIT margin | 2.4% | 2.4% | -0.6% | -4.3% | -12.7% | -17.4% | -12.5% | -4.3% |
Pre-tax income | 10.7 | 5.9 | -143.4 | -69.1 | -113.2 | -118.7 | -115.9 | -163.8 |
Income taxes | 0.0 | 3.4 | -10.6 | -10.7 | -31.4 | -13.5 | -20.1 | -33.1 |
Tax rate | 0.0% | 57.5% | 7.4% | 15.5% | 27.7% | 11.4% | 17.3% | 20.2% |
Net income | 4.0 | -0.6 | -136.1 | -60.3 | -131.8 | -105.7 | -96.4 | -131.8 |
Net margin | 0.6% | -0.1% | -25.7% | -11.4% | -28.2% | -27.7% | -24.3% | -25.4% |
|
Diluted EPS | | ($0.04) | ($9.64) | ($4.33) | ($10.06) | ($0.82) | ($0.90) | ($1.24) |
Shares outstanding (diluted) | | 14.2 | 14.1 | 13.9 | 13.1 | 128.4 | 107.0 | 106.6 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|